65th American Society of Hematology (ASH) Annual Meeting - X4 Pharmaceuticals

65th American Society of Hematology (ASH) Annual Meeting

65th American Society of Hematology (ASH) Annual Meeting

December 2023

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, Open-Label, Multicenter Study Support Reduction in G-CSF Dosing

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics